Marta García López
Investigador post-doc
Research group
Research line:
New therapeutic strategies for High-risk neuroblastoma
Researcher Marta Garcia graduated in Biotechnology and Biochemistry in 2007 from the Autonomous University of Barcelona (UAB) and obtained her PhD in Biomedicine from the UAB in 2013. Also, the Autonomous University of Barcelona, in 2016, awarded her with an Extraordinary Doctoral Award for her thesis based on the generation and characterization of metastatic models in prostate cancer.
During her training stay, she received a scholarship to develop her doctorate at the Institut de Recerca Vall d'Hebron in Barcelona and two travel grants awarded by the Red Temática de Investigación Cooperativa en Cáncer (RTICC) to attend two international conferences in Lithuania and Paris.
In 2014 she joined as a postdoctoral researcher in the Tumors of Development research group at the Institut de Recerca Sant Joan de Déu, first under the direction of Dr. Carmen de Torres and in 2020 she joined the group of Translational Genomics of Dra. Cinzia Lavarino. Her current scientific interests include the development of new strategies to treat neuroblastic tumors, in particular the most aggressive and chemoresistant ones that escape the current standard treatment. She is also interested in the study of new biomarkers of both diagnosis and prognosis focused on this tumor type and in other developmental tumors.
Last Publications
- Gomez-Gonzalez S, Llano-Viles J, Garcia-López M, Garrido- García A, Suñol M, Lemos I, Pérez-Jaume S, Salvador-Marcos N, Gene-Olaciregui N, Galán RA, Santa-María López V, Pérez-Somarriba M, Castañeda-Heredia A, Hinojosa J, Winter U, Moreira FB, Lubieniecki F, Vazquez V, Mora J, Cruz-Martínez O, Morales-La Madrid A, Perera A and Lavarino C EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping iScience . 26(9): 107598-107598.
- García-Gerique L, Garcia-López M, Garrido- García A, Gómez-González S, Torrebadell-Burriel M, Prada-Varela E, Pascual-Pastó G, Muñoz-Aznar O, Pérez-Jaume S, Lemos I, Salvador-Marcos N, Vilà-Ubach M, Doncel-Requena A, Suñol M, Carcaboso AM, Mora J and Lavarino C MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment BMC Cancer . 22(1): 669-669.
- Gonçalves-Alves E, Garcia-López M, Rodriguez-Hernandez CJ, Gomez-Gonzalez S, Ecker RC, Suñol M, Muñoz-Aznar O, Carcaboso AM, Mora J, Lavarino C and Mateo-Lozano S AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(8): 4323.
Projects
- Project name:
- Multi-ómica y cribado masivo de fármacos para el tratamiento dirigido del Neuroblastoma resistente al tratamiento
- Leader
- Cinzia Emilia Lavarino , Marta García López
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI23/00120
- Starting - finishing date:
- 2024 - 2026
- Project name:
- SGR 2022-2024_Grup de recerca en tumors del desenvolupament
- Leader
- Jaume Mora Graupera
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01612
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Desarrollo de clasificadores epigenéticos para el Cáncer Pediátrico (ECPC)
- Leader
- Cinzia Emilia Lavarino
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI20/00519
- Starting - finishing date:
- 2021 - 2025
More activities
-
#SeminarIRSJD · Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in neuroblastoma
Auditori J. Plaza · Hospital Sant Joan de Déu Barcelona